REG - Cambridge Cognition - Appointment of Non-Executive Director

Cambridge Cognition HoldingsAnnouncement

01/07/2019 07:05

RNS Number : 9043D
Cambridge Cognition Holdings PLC
01 July 2019
 


Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
 
Appointment of Non-Executive Director
 
The neuroscience technology company, Cambridge Cognition Holdings plc (AIM: COG), which develops and markets neuroscience technologies to assess brain health, is pleased to announce the appointment of Debra Leeves as a Non-Executive Director with immediate effect.
 
Debra is currently CEO of Vertual, the leading provider of virtual and augmented reality training simulation systems in radiotherapy. She has over 25 years of experience in the medical technology and biotechnology industries, and has previously been COO of Beckley Canopy Therapeutics, CEO of Physeon and also held senior roles with companies such as Rex Bionics, Avita Medical, Merck, GlaxoSmithKline, GE Healthcare and Pfizer.
 
Matthew Stork, CEO of Cambridge Cognition said:
"We are delighted that Debra has joined the Board. Debra brings with her an immense amount of knowledge and expertise in successful global medical technology businesses and clinical trial management within major pharmaceutical companies.  Her experience will be invaluable as we continue the growth of Cambridge Cognition."
 
The following information regarding Debra Marie Leeves (aged 57) is disclosed under Schedule 2(g) of the AIM Rules for Companies:
 



Current Directorships


Directorships held in past 5 years




Vertual Limited
Oxford Box Ltd
DML Solutions Limited


Physeon GmbH



 
As at the date of this announcement, Mrs Leeves is not beneficially interested in any Ordinary Shares in the Company.
 
There are no other matters which are required to be announced under Schedule 2(g) of the AIM Rules for Companies.
 
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
 
Enquiries
 



Cambridge Cognition Holdings PLC
Matthew Stork, Chief Executive Officer
Nick Walters, Chief Financial Officer


 
Tel: 01223 810 700
press@camcog.com




finnCap Ltd (NOMAD and Joint Broker)
Geoff Nash / Simon Hicks
Alice Lane / Manasa Patil


Tel: 020 7220 0500
(Corporate Finance)
(ECM)




Dowgate Capital Limited (Joint Broker)
David Poutney / James Serjeant


Tel: 020 3903 7715
 




IFC Advisory Ltd (Financial PR and IR)
Tim Metcalfe / Miles Nolan / Zach Cohen


Tel: 020 3934 6630
 




About Cambridge Cognition


Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.
 
For further information visit www.cambridgecognition.com
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBUGDLCDDBGCI